ro7171009
mAbexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Sep 21, 2017 (NCT03295877)
Timeline
Indications
Mechanism of action
- Serine protease HTRA1Immunity, passive
HTRA1 immunity, passive
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04607148 | Phase 2 | Nov 16, 2020 | Genentech, Roche |
| NCT03972709 | Phase 2 | Jun 3, 2019 | Genentech, Roche |
| NCT03295877 | Phase 1 | Sep 21, 2017 | Genentech, Roche |
Showing 3 of 3 trials
Page 1 / 1